Ixekizumab
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Ixekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $698 million on Ixekizumab across 85,000 claims for 14,000 beneficiaries.
Ixekizumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $7370.72 to $7435.87 per ML — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$7370.72 – $7435.87
per ML
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Interleukin-17A Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing IXEKIZUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TALTZ 80 MG/ML AUTOINJECTOR (2-PACK) | $7435.8708 per ML | — |
TALTZ 80 MG/ML SYRINGE | $7402.0679 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR (3-PACK) | $7388.2220 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR | $7370.7151 per ML | -0.04% |
Frequently Asked Questions
What is Ixekizumab used to treat?
Ixekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Ixekizumab?
In 2024, Medicare Part D spent $698 million on Ixekizumab across 85,000 claims for 14,000 beneficiaries.
How many Ixekizumab products are on the market?
The Ixekizumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Ixekizumab?
NADAC reference prices for Ixekizumab range from $7370.7151 to $7435.8708 per ML — a 1% difference between cheapest and most expensive.
Which manufacturers make Ixekizumab?
1 manufacturer lists Ixekizumab in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (4).
How has the price of Ixekizumab changed recently?
Over the past 7 days, 0 Ixekizumab NDCs rose and 1 fell, with a market-wide average change of -0.0%.